Managing IP Awards 2022: in-house submissions open

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Managing IP Awards 2022: in-house submissions open

Managing IP APAC Awards

We have started accepting submissions from in-house counsel and teams for the 17th annual Managing IP Awards programme

The annual Managing IP Awards programme recognises remarkable IP achievements and developments in law firms and companies.

The programme covers several IP practice areas and more than 50 jurisdictions. 

The in-house categories recognise teams for their achievements or work in and outside their companies.

 


Nominate your in-house team

We have today launched the research for the in-house categories and invite in-house practitioners to participate by completing our awards form (click here to download the form).

Please upload your completed document to our in-house awards submission portal here. The submission deadline is January 27 2022.

We will use the information submitted, alongside other research data, to decide the shortlists and winners. Subject to research data, we will recognise in-house teams and practitioners in different areas of IP law or for IP in general.

You will find more details and guidelines in our research form.

If you have any questions about our in-house awards, please contact John Harrison.



The timeline for the awards

Managing IP will host three awards ceremonies in 2022, starting with the EMEA Awards in March. We will reveal the location/format and exact dates next year.

November 25: In-house awards submission portal opens here

January 27: In-house awards submission deadline

March: EMEA Awards ceremony (shortlist published in February)

April: Americas Awards ceremony (shortlist published in February)

May: Asia-Pacific Awards ceremony (shortlist published in March)

 

 

 


About the Managing IP Awards

Managing IP launched its awards programme in 2006. The programme has evolved and grown over the years: we now host regional ceremonies, instead of a global ceremony in London, and the research covers more than seven IP practice areas and over 50 jurisdictions.

The awards ceremonies attract hundreds of guests, including in-house counsel and prominent public officials in IP. It is widely regarded as the premier IP law firm awards event in the legal industry.

The awards are based on information obtained from different sources, including submissions from law firms and companies, market feedback surveys, and publicly available information. See this year’s in-house winners for the EMEA Awards here and the Americas Awards here.

Read about our research methodology and the previous awards here.

more from across site and SHARED ros bottom lb

More from across our site

Litigation team says pre-trial work and a Section 101 defence helped significantly limit damages payable by ride-sharing firm Lyft in patent case
News of Avanci hiring a senior vice president and the EPO teaming up with a French AI startup were also among the top talking points
Explosm, the independent Texas studio behind the hit webcomic Cyanide & Happiness, partnered with Temu’s IP protection team to combat counterfeiters infringing on its brand
The latest in a dispute over juicing machines, and a shakeup in judicial compositions were also among the top developments
Patent partner Robert Hollingshead explains why the firm remains committed to Japan despite several US firms exiting the Japanese and greater Asia market
Emma Green, partner at Bird & Bird, shares why the Iceland v Iceland dispute could prompt businesses and lawyers to think differently about brand enforcement
Attain IP, developed by two UK patent lawyers, will meet ‘forensic’ needs of patent attorneys by showing a verifiable reasoning chain, according to its co-founders
The High Court of Australia has allowed a fashion designer to retain her registered ‘Katie Perry’ trademark for clothing
Sim & San secured the win for Dr. Reddy’s, which will allow the pharma company to manufacture and export semaglutide, the active ingredient in Ozempic
Lucas Amodio joins our ‘Five minutes with’ series to discuss artificial intelligence systems and patent law
Gift this article